Indapamide Hemihydrate Crescent Pharma (Indapamide Hemihydrate)

Indapamide blocks the sodium‑chloride transporter in the distal convoluted tubule of the kidney, decreasing reabsorption of these ions. This leads to increased urine output, reduced plasma volume, and lower peripheral resistance. The combined diuretic and vasodilatory actions result in a measurable drop in arterial blood pressure.

The exact dose is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Healthcare providers select the appropriate strength and dosing schedule, which may be adjusted during follow‑up visits to achieve optimal blood‑pressure control or edema reduction.

Safety data for Indapamide in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and required import documentation.

Indapamide belongs to the thiazide‑like class and generally offers a longer half‑life and a more pronounced vasodilatory effect than traditional thiazides like hydrochlorothiazide. Clinically, it may provide better blood‑pressure control with a lower incidence of metabolic disturbances, though individual response varies and choice depends on patient‑specific factors.

Store the tablets at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or extreme heat.

Indapamide is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether it should be taken in the morning to reduce the likelihood of nocturnal urination.

The most critical risks include severe dehydration, significant electrolyte imbalances such as hyponatremia or hypokalemia, and rare allergic reactions that may present as rash, angioedema, or anaphylaxis. Prompt medical attention is required if any of these serious symptoms develop.

Indapamide is contraindicated in patients with anuria, severe renal impairment, or known hypersensitivity to the drug or other thiazide‑like diuretics. Caution is also advised for individuals with severe hepatic disease, uncontrolled diabetes, or those taking medications that may cause dangerous electrolyte disturbances.